Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
Cannabis Stocks Retreat On New Rescheduling Order Developments: What’s Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has stalled.
Bullish Monday For Marijuana Stocks – Target Group, Item 9 Labs Among Top Gainers
GAINERS: Target Group (OTC:CBDY) shares closed up 50.00% at $0.00 Global Compliance (OTC:FUAPF) shares closed up 46.35% at…
EXCLUSIVE: ‘Cannabis Is Just Getting Started,’ Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and one day, interstate commerce." That's according to Benzinga's cannabis stock expert, Michael Berger, who is on a mission to uncover the most promising marijuana stocks poised for growth, even in a dull market.
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies’ Risk-Return Profiles
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs).
Marijuana Stock Movers For May 1, 2024
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 86.36% at $0.04 Pharmadrug (OTC:LMLLF) shares closed up 18.72% at…
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.
DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses
Cannabis stocks soared following Tuesday's news that the DEA intends to designate marijuana from Schedule I to Schedule III.
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news that the Drug Enforcement Administration’s (DEA) historic…
State-Run Vs. Private: Pennsylvania Debates Transition Of Liquor Store Model To Cannabis Distribution
The conversation around cannabis legalization in Pennsylvania is pivoting towards a potential state-run model, akin to the existing system for alcohol sales.